(RTTNews) - Biohaven Ltd. (BHVN) and Merus N.V. (MRUS) announced a research collaboration and licensing agreement aimed at co-developing three innovative bispecific antibody drug conjugates (ADCs).
(RTTNews) - Biohaven Pharmaceuticals (BHVN), on Tuesday announced that the FDA has accepted its New Drug Application for Troriluzole for the treatment of adult patients with spinocerebellar ataxia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback